Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring
CONCLUSIONS
This is the first observational study to show that NAFLD is independently associated with an increased risk of prevalent ventricular arrhythmias in patients with type 2 diabetes.
Source: Diabetes Care - Category: Endocrinology Authors: Mantovani, A.; Rigamonti, A.; Bonapace, S.; Bolzan, B.; Pernigo, M.; Morani, G.; Franceschini, L.; Bergamini, C.; Bertolini, L.; Valbusa, F.; Rigolon, R.; Pichiri, I.; Zoppini, G.; Bonora, E.; Violi, F.; Targher, G. Tags: Cardiovascular and Metabolic Risk Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Cardiovascular | Chronic Kidney Disease | Chronic Obstructive Pulmonary | Diabetes | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | Heart | Heart Disease | Hypertension | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Smokers | Study | Urology & Nephrology | Ventricular Tachycardia